Sedation drug for children on breathing machines in intensive care
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests a drug called dexmedetomidine to help sedate children who need a breathing machine for more than 12 hours. It may reduce confusion (delirium) compared to usual sedatives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 month and 17.5 years old.
- Your child is on a breathing machine and has been sedated for less than 6 hours.
- Your child is expected to need the breathing machine for more than 12 hours.
- Your child is treated in a participating French intensive care unit.
- You can give consent for your child to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an early sedation medicine called dexmedetomidine in patients 65 and older who need a breathing tube. It may help reduce confusion and time on the machine compared to usual care.
This trial tests a medicine called dexmedetomidine to keep premature babies calm and comfortable while they are on a breathing machine. It may help reduce pain and stress for your baby during this difficult time.
This study tests a combination of two medicines (dexmedetomidine and esketamine) to help ICU patients who are on a breathing machine feel calm and have less pain. The goal is to find a safe and effective way to keep patients comfortable while they recover.
This study compares two sedative medicines, dexmedetomidine and midazolam, to see which one helps preterm babies on a ventilator breathe on their own sooner. Your baby may be eligible if they were born very early and need medicine to relax while on the breathing machine.
This study tests whether a drug called dexmedetomidine (a sedative) can help calm patients with severe brain injury who are on a breathing machine in the intensive care unit. If you or your loved one is in this situation, this treatment might reduce agitation and improve recovery.
This trial tests whether combining two sedative medications, esketamine and dexmedetomidine, is safer and more effective than using dexmedetomidine alone for treating hyperactive delirium in ICU patients who need breathing support. If you or a loved one are experiencing severe confusion and agitation while on a breathing machine, this study may offer a new treatment option.
Hear when a new Delirium in the Intensive Care Unit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.